Session Details
[1-YIA-B]YIA UG
Mon. Mar 16, 2026 1:00 PM - 2:00 PM JST
Mon. Mar 16, 2026 4:00 AM - 5:00 AM UTC
Mon. Mar 16, 2026 4:00 AM - 5:00 AM UTC
YIA UG(C202)
[1-YIA-B-21]In vivo analysis of circulatory dysfunction in a sepsis model mouse
*Sota Kasahara1, Yukino Akimaru1, Koki Ishiyama1, Masami Kodama1, Yoichi Sunagawa2, Satoshi Shimizu1, Yasuhide Watanabe1, Kazuho Sakamoto3, Tetsuo Sasano4, Naoyuki Matsuda5, Junko Kurokawa1 (1. Dept. Bio-inform. Pharmacol., University of Shizuoka, Shizuoka, Shizuoka, Japan, 2. Div. Mol. Med., University of Shizuoka, Shizuoka, Shizuoka, Japan, 3. Dept. Pharm. Sci., International Univ. of Health and Welfare, Ohtawara, Tochigi, Japan, 4. Dept. Cardiovasc. Med., Institute of Science Tokyo, Tokyo, Japan, 5. Dept. Emerg. Intensive Care Med., Nagoya University, Nagoya, Aichi, Japan)
[1-YIA-B-22]Analysis of sex differences in cardiac function using induced pluripotent stem cells derived from a pair of dizygotic twins
*Akihito Ota1, Masashi Wakabayashi1, Keisuke Ando1, Satoshi Shimizu1, Kazuho Sakamoto2, Masami Kodama1, Yoichi Sunagawa3, Yasunari Kanda4, Tatsuya Morimoto3,5, Junko Kurokawa1 (1. University of Shizuoka School of Pharmaceutical Sciences, 2. Dept. Pharm. Sci., International Univ. of Health and Welfare, Ohtawara, Tochigi, Japan, 3. Div. Mol. Med., University of Shizuoka, Shizuoka, Shizuoka, Japan, 4. Div. Pharmacol., NIHS, Kawasaki, Kanagawa, Japan, 5. Dept. Pharmacol., Toho university, Ota, Tokyo, Japan)
[1-YIA-B-23]Investigation of the involvement of PKCβ in age-related renal injury
*Miku Murakoshi1, Masashi Mukohda1, Tomoko Kodama1, Risuke Mizuno1 (1. Laboratory of Veterinary Pharmacology, Faculty of Veterinary Medicine, Okayama University of Science)
[1-YIA-B-24]Generating missense mouse models of the hereditary kidney disease Alport Syndrome
*Riko Kato1 (1. Kumamoto university)
[1-YIA-B-25]Nicotinamide Mononucleotide, a Precursor of NAD+, Alleviates Doxorubicin-induced Kidney Injury in Mice
*Tomoki Hori1, Koki Abe1,2, Ryusuke Hosoda1, Ryo Numazawa1,3, Mizuna Miyazaki1, Yukika Saga1, Yuki Tatekoshi1,2, Atsushi Kuno1,2 (1. Department of Pharmacology, Sapporo Medical University School of Medicin, 2. Division of Cardiovascular-Kidney-Metabolic Medicine, Department of Internal Medicine, Sapporo Medical University School of Medicine, 3. 3) Research Fellow (DC1) of the Japan Society for the Promotion of Science (JSPS))
[1-YIA-B-26]Analysis of emotional and cognitive functions in FADS1/2 deficient mice under semi-naturalistic conditions using the IntelliCage
*Rin Aizawa1, Hisayoshi Kubota1, Mark Chiristian Guinto2, Xinjian Zhang1, Yu Wen1, Masoumeh Khalili1, Xinzhu Zhou1, Akira Sobue1, Taku Nagai1 (1. Division of Behavioral Neuropharmacology, International Center for Brain Science(ICBS), Fujita Health University, 2. Institute for Quantitative Biosciences(IQB), The University of Tokyo)
[1-YIA-B-27]Neuronal mechanisms underlying the therapeutic effects of atomoxetine on ADHD-like phenotypes in offspring mice of a sire chronically exposed to nicotine
*Fumiya Nishimura1, Daisuke Ibi1, Genki Nakasai1, Ayana Ando1, Kota Hayakawa1, Takayoshi Mamiya1, Masayuki Hiramatsu1 (1. Meijo University)
[1-YIA-B-28]Exploration of compounds with high activity at the serotonin 5-HT2A receptor using an in vitro assay
*Shoya Uno1, Daisuke Ibi1, Anna Ookura1, Iroha Kondo1, Takayoshi Mamiya1, Yuki Hitora2, Masayuki Hiramatsu1 (1. Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, 2. Department of Natural Medicines, Graduate School of Pharmaceutical Sciences, Kumamoto University)
[1-YIA-B-29]Changes in social behavior and gene expression in ventral hippocampus of offspring from obese mice
*Hideki Nakano1, Tomohiro Kamata1, Hiroko Ikeda1 (1. hoshi university)
[1-YIA-B-30]Single-particle tracking reveals spatiotemporal dynamics of Neurexin during early synapse formation
*Kodai Sasaki1, Shigeyuki Namiki1, Daisuke Asanuma2, Kenzo Hirose1 (1. The University of Tokyo Graduate School of Medicine, 2. Institute of Science Tokyo Institute of Integrated Research Laboratory for Chemistry and Life Science)
[1-YIA-B-31]Temporal coding of stress by noradrenaline in the hypothalamus
*Ryunosuke Ono1, Keiichi Itoi2, Kenji Sakimura3, Takuya Sasaki4,5, Hiroyuki Igarashi4 (1. Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku University, 2. Department of Clinical Immunology and Rheumatology, Graduate School of Medicine, Tohoku University, 3. Department of Animal Model Development, Brain Research Institute, Niigata University, 4. Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 5. Department of Neuropharmacology, Graduate School of Medicine, Tohoku University)
[1-YIA-B-32]The effect of CRABP1 expression on temozolomide sensitivity in glioblastoma cells
*Mizuki Umemura1, Urara Kudo1, Shinsuke Nakamura1, Masamitsu Shimazawa1 (1. Gifu Pharmaceutical University)
[1-YIA-B-33]Effect of tumor formation on neuronal activity in the paraventricular nucleus of the hypothalamus after restraint stress
*Rin Kazuma1, Takumu Yamasaki1, Yusuke Onaka1, Taro Yamaguti1, Masanori Yoneyama1 (1. Setsunan University)
[1-YIA-B-34]Behavioral and neuronal responses to inequity in mice
*Keita Deminami1, Hitoshi Hashimoto1,2,3,4,5, Atsushi Kasai1,6 (1. Lab. Mol. Neuropharmacol., Grad. Sch. Pharmaceut. Sci., Osaka Univ., 2. United Grad. Sch. Child Dev., Osaka Univ., 3. Inst. Datability Sci., Osaka Univ., 4. Inst. Open Transdiscip. Res. Initi., Osaka Univ., 5. Grad. Sch. Med., Osaka Univ., 6. Dep. Systems Neuropharmacol., Res. Inst. Env. Med., Nagoya Univ.)
[1-YIA-B-35]Effect of tumor formation on hippocampal responsiveness to lipopolysaccharide
*Daiki Asao1, Aina Nakada1, Yusuke Onaka1, Taro Yamaguchi1, Masanori Yoneyama1 (1. Setsunan Univ.)